Related references
Note: Only part of the references are listed.The first-in-human study of the pan-PIM kinase inhibitor PIM447 in patients with relapsed and/or refractory multiple myeloma
Marc S. Raab et al.
LEUKEMIA (2019)
PIM-2 protein kinase negatively regulates T cell responses in transplantation and tumor immunity
Anusara Daenthanasanmak et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
A novel, dual pan-PIM/FLT3 inhibitor SEL24 exhibits broad therapeutic potential in acute myeloid leukemia
Wojciech Czardybon et al.
Oncotarget (2018)
PIM-1 mRNA expression is a potential prognostic biomarker in acute myeloid leukemia
Hui Cheng et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2017)
Rational Design of a Potent Pan-Pim Kinases Inhibitor with a Rhodanine-Benzoimidazole Structure
Yuichi Sawaguchi et al.
ANTICANCER RESEARCH (2017)
Expression of PIM kinases in Reed-Sternberg cells fosters immune privilege and tumor cell survival in Hodgkin lymphoma
Maciej Szydlowski et al.
BLOOD (2017)
Pan-PIM Kinase Inhibition Provides a Novel Therapy for Treating Hematologic Cancers
Pablo D. Garcia et al.
CLINICAL CANCER RESEARCH (2014)
Differential expression of Pim-3, c-Myc, and p-p27 proteins in adenocarcinomas of the gastric cardia and distal stomach
Yuehong Li et al.
TUMOR BIOLOGY (2014)
EBNA3C Augments Pim-1 Mediated Phosphorylation and Degradation of p21 to Promote B-Cell Proliferation
Shuvomoy Banerjee et al.
PLOS PATHOGENS (2014)
Expression of pim-1 in Tumors, Tumor Stroma and Tumor-Adjacent Mucosa Co-Determines the Prognosis of Colon Cancer Patients
Yong-hai Peng et al.
PLOS ONE (2013)
Functional Role and Therapeutic Potential of the Pim-1 Kinase in Colon Carcinoma
Ulrike Weirauch et al.
NEOPLASIA (2013)
Mechanisms of cytotoxicity to Pim kinase inhibitor, SGI-1776, in acute myeloid leukemia
Lisa S. Chen et al.
BLOOD (2011)
Structure-Activity Relationships of Phosphoinositide 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Dual Inhibitors: Investigations of Various 6,5-Heterocycles to Improve Metabolic Stability
Markian M. Stec et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Pim-1 plays a pivotal role in hypoxia-induced chemoresistance
J. Chen et al.
ONCOGENE (2009)
The generalized Born/volume integral implicit solvent model: Estimation of the free energy of hydration using London dispersion instead of atomic surface area
Paul Labute
JOURNAL OF COMPUTATIONAL CHEMISTRY (2008)
Proto-oncogene, Pim-3 with serine/threonine kinase activity, is aberrantly expressed in human colon cancer cells and can prevent Bad-mediated apoptosis
Boryana Konstantinova Popivanova et al.
CANCER SCIENCE (2007)
Pim-3, a proto-oncogene with serine/threonine kinase activity, is aberrantly expressed in human pancreatic cancer and phosphorylates Bad to block Bad-mediated apoptosis in human pancreatic cancer cell lines
Ying-Yi Li et al.
CANCER RESEARCH (2006)
Pim-1 kinase promotes inactivation of the pro-apoptotic bad protein by phosphorylating it on the Ser112 gatekeeper site
TLT Aho et al.
FEBS LETTERS (2004)
Mice deficient for all PIM kinases display reduced body size and impaired responses to hematopoietic growth factors
H Mikkers et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
The PIM-2 kinase phosphorylates BAD on serine 112 and reverses BAD-induced cell death
B Yan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The serine/threonine kinase Pim-2 is a transcriptionally regulated apoptotic inhibitor
CJ Fox et al.
GENES & DEVELOPMENT (2003)
FLT3 mutations in acute myeloid leukemia cell lines
H Quentmeier et al.
LEUKEMIA (2003)
High-throughput retroviral tagging to identify components of specific signaling pathways in cancer
H Mikkers et al.
NATURE GENETICS (2002)
Delineation of prognostic biomarkers in prostate cancer
SM Dhanasekaran et al.
NATURE (2001)
Share Paper
